HomeNewsBusinessMoody's says coronavirus-triggered global recession to keep pressure on APAC non-financials

Moody's says coronavirus-triggered global recession to keep pressure on APAC non-financials

Moody's said although fiscal and monetary stimulus programmes in both advanced and emerging markets have helped stabilise financial markets and provided temporary relief to companies, operating performance and financing capability of companies are vulnerable to financial market shocks, particularly if a second wave of infections results in renewed lockdowns.

July 16, 2020 / 15:41 IST
Story continues below Advertisement

Moody's Investors Service on July 16 said the coronavirus-triggered global recession will continue to put pressure on non-financial companies in Asia-Pacific, and negative credit trends will persist through the rest of 2020.

It said although fiscal and monetary stimulus programmes in both advanced and emerging markets have helped stabilise financial markets and provided temporary relief to companies, operating performance and financing capability of companies are vulnerable to financial market shocks, particularly if a second wave of infections results in renewed lockdowns.

Story continues below Advertisement

“We expect the recovery from this recession to be prolonged, although the easing of lockdown measures should support a gradual recovery in H2. The ability of businesses to recover will depend on the pace at which consumer demand rebounds, which in turn hinges on governments' ability to restore confidence by reducing fear of contagion,” Moody's Group Credit Officer and Senior Vice President Clara Lau said.

Moody's said the outlook remains highly uncertain for all Asia-Pacific (APAC) economies, with pace of recovery uneven across all countries.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show